What's the difference between a 500-year flood and a 1000-year flood? Trump threatens to impose up to 200% tariff on pharmaceuticals 'very soon' This Is One of the Best Places to Retire in the U.S.

Scott Vogelsberg explores the biotech space and the changing nature of the relationship between pharma and biotech. As the pharmaceutical industry has struggled to address barren pipelines, the ...

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough ...

JCR Pharmaceuticals has signed a licence agreement with Alexion, AstraZeneca Rare Disease, for its proprietary JUST-AAV ...

Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.

Merck on Wednesday appeared to take a step towards addressing the looming Keytruda patent cliff. The company is closing in on ...

When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...

HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...

Every year, horseshoe crabs are harvested for their blue blood, but alternatives are now coming through that could help ...

This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.

Trump floats 200% tariff on medicines, while threat of 50% levy on copper imports sent price of metal to record high ...

Discover how pharmaceutical companies can form mutually beneficial partnerships with biotech and digital health start-ups to drive innovation and growth in the industry.